Beta-Blockers is benefit high risk patients around time of noncardiac, nonvascular surgery
FDA Highlights by Bruce Sylvester – Patients with an elevated cardiac risk treated with beta-blockers on the day of or day following non-cardiac, non-vascular surgery have achieved significantly… read more.